Fermenta Biotech Limited (NSE:FERMENTA)

India · Delayed Price · Currency is INR

459.45

+4.35 (0.96%)

At close: Jul 16, 2026

48.19% (1Y)

Market Cap	12.70B +14.0%
Revenue (ttm)	5.25B +11.9%
Net Income	717.65M -6.6%
EPS	24.51 -7.0%
Shares Out	n/a
PE Ratio	17.70
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	149,942
Open	460.80
Previous Close	455.10
Day's Range	449.00 - 465.70
52-Week Range	248.85 - 479.45
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Fermenta Biotech

Fermenta Biotech Limited, together with its subsidiaries, manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally. It provides pharmaceutical formulations and environmental solutions; rents and sells properties; and sports and health awareness/education services. The company also offers various variants of vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder for use in various applications, such as pharmaceuticals, dietary and nutritional sup... [Read more]

Industry Pharmaceutical Preparations

Founded 1951

Employees 606

Stock Exchange National Stock Exchange of India

Ticker Symbol FERMENTA

Full Company Profile

Financial Performance

In fiscal year 2026, Fermenta Biotech's revenue was 5.25 billion, an increase of 11.92% compared to the previous year's 4.69 billion. Earnings were 717.65 million, a decrease of -6.63%.

Financial Statements